|
News -
Health News
|
|
Written by Administrator
|
|
Monday, 15 June 2009 20:07 |
Research News on the Reishi Mushroom
The Reishi Mushroom is a Chinese variety which has an array of reputed health benefits including antioxidant properties. In Ancient China, the dried reishi powder was used as cancer chemotherapy. Many studies with reishi extract show its myriad health benefits.
The mushroom contains over 100 substances known to support our immune defenses including polysaccharides that stimulate spleen cell proliferation and cytokine expression. In one study, reishi suppressed cell adhesion and migration of highly invasive breast and prostate cancer cells, suggesting its potency to reduce tumors. Reishi clearly demonstrates anti-cancer activity in experiments with cancer cells.
A study completed by Queen Elizabeth Hospital in Hong Kong in 2007 published in the International Journal of Surgical Pathology showed “Regression of gastric large B-Cell lymphoma accompanied by a florid lymphona-like T-cell reaction; immunomodulatory effect of Ganoderma lucidum Reishi?” Other extensive medical reports published in medical journals demonstrate the anti-cancer effect of Reishi.
One resource for mushroom information is The Wild Rose College of Healing in Alberta, Canada. Check out their webpage on mushrooms. In her article on mushrooms, Wild Rose College founder Terry Willard Cl.H, Ph.D explains about candida and the use of mushrooms: "As you can see with the huge amount of both folklore and scientific information, these medicinal mushrooms can play an important role in almost anyone`s health program. Even though it is true that several mushrooms should not be consumed by people with Candida Yeast infections, all of these mushrooms (reishi, maitaki and shiitaki) are not only safe in these patients, they can often reduce the symptoms and underlying causes of this problem." If you have any doubts about your medical condition regarding taking Reishi, consult with your medical doctor. See our disclaimer.
|
|
Last Updated on Tuesday, 16 June 2009 21:06 |